Research
Endocannabinoid Receptors as a Therapeutic Target in Epilepsy Treatment
This research area focuses on how the modulation of endocannabinoid receptors (primarily CB1 and CB2) can control or prevent epileptic seizures. The endocannabinoid system (ECS) plays a key role in inhibiting neuronal hyperexcitability, which is the underlying cause of seizures.
Epigenetic regulation in epilepsy and its impact on CNS–periphery communication mediated by extracellular vesicles
Epilepsy is intrinsically linked to long-lasting changes in gene expression. Epigenetic regulation provides the explanatory framework for how these long-term functional changes are established and maintained, independently of the DNA sequence. Studying these mechanisms allows us to identify therapeutic targets capable of preventing or halting disease progression, rather than merely controlling symptoms.
